Rezultati - Amer Jamalpoor
- Showing 1 - 2 results of 2
-
1
Brain accumulation of osimertinib and its active metabolite AZ5104 is restricted by ABCB1 (P-glycoprotein) and ABCG2 (breast cancer resistance protein) od Stéphanie van Hoppe, Amer Jamalpoor, Johannes J.M. Rood, Els Wagenaar, Rolf W. Sparidans, Jos H. Beijnen, Alfred H. Schinkel
Izdano 2019Artigo -
2
Cysteamine–bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis od Amer Jamalpoor, Charlotte AGH van Gelder, Fjodor A. Yousef Yengej, Esther A. Zaal, Sante Princiero Berlingerio, Koenraad Veys, Carla Pou Casellas, Koen Voskuil, Khaled Essa, Carola M. E. Ammerlaan, Laura Rita Rega, Reini E.N. van der Welle, Marc R. Liliën, Maarten B. Rookmaaker, Hans Clevers, Judith Klumperman, Elena Levtchenko, Celia R. Berkers, Marianne C. Verhaar, Maarten Altelaar, Rosalinde Masereeuw, Manoe J. Janssen
Izdano 2021Artigo
Iskalna orodja:
Sorodne teme
Biochemistry
Cancer research
Chemistry
Gene
Internal medicine
Medicine
Pharmacology
ATP-binding cassette transporter
Abcg2
Acute kidney injury
Biology
Blood–brain barrier
Cancer
Central nervous system
Cysteamine
Cysteine
Cystine
Cystinosis
Disease
Distal convoluted tubule
Drug resistance
Endocrinology
Enzyme
Epidermal growth factor receptor
Erlotinib
Fanconi syndrome
Genetically modified mouse
Genetics
Kidney
Lysosomal storage disease